Key result
Indomethacin treatment in rats significantly decreased urinary sodium excretion and particulate guanylyl cyclase activity, while increasing soluble guanylyl cyclase activity and NOS expression.
Why the study?
Does indomethacin alter the local atrial natriuretic peptide (ANP) and nitric oxide (NO) systems in the kidney of male Sprague-Dawley rats?
Does indomethacin alter the local atrial natriuretic peptide (ANP) and nitric oxide (NO) systems in the kidney of male Sprague-Dawley rats?
Indomethacin decreases urinary sodium excretion in rats, likely due to decreased activity of the local ANP/cGMP system, with a compensatory increase in the NO/cGMP system.
Effects of non-steroidal anti-inflammatory drugs on the local atrial natriuretic peptide (ANP) and nitric oxide (NO) systems in the kidney were investigated. 2. Male Sprague-Dawley rats were treated with indomethacin (5 mg/kg, every 12 h, i.p.) for 2 days. The expression of ANP and natriuretic peptide receptor-A (NPR-A) mRNA was determined in the kidney, as was that of endothelial NO synthase (NOS) proteins. Particulate and soluble guanylyl cyclase activities were determined separately. 3. Following treatment with indomethacin, urinary sodium excretion decreased significantly. Although the renal expression of ANP was not changed significantly, that of NPR-A decreased significantly. The expression of NOS increased significantly. Particulate guanylyl cyclase activity was decreased, whereas the activity of soluble guanylyl cyclase was increased. The catalytic activity of Na(+)/K(+)-ATPase was increased, with no significant changes in its expression. The expression of the type 3 Na/H exchanger and Na-K-2CL cotransporters increased significantly. 4. The indomethacin-induced decrease in urinary sodium excretion may be attributed, at least in part, to decreased activity of the local ANP/cGMP system. The increased activity of the NO/cGMP system may be a compensatory response to the diminished activity of the prostaglandin system.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2004) studied this question. Indomethacin was evaluated on Urinary sodium excretion and guanylyl cyclase activities. Indomethacin treatment in rats significantly decreased urinary sodium excretion and particulate guanylyl cyclase activity, while increasing soluble guanylyl cyclase activity and NOS expression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: